Rituximab
Onco
Daily
Twitter
Facebook
Youtube
RSS Feed
Linkedin
Facebook
RSS
Twitter
Youtube
Linkedin
May, 2024
May 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
« Apr
Rituximab
May 2, 2024, 01:59 |
Blog
Nihar Desai: How we name monoclonal antibodies?
Nihar Desai, Consultant Hemato-Oncologist at Princess Margaret Cancer Centre, shared on X/Twitter: "Hey NEET PG aspirants!…
Feb 3, 2024, 13:53 |
Drugs
Talha Badar: Upfront immunotherapy with or without chemotherapy for precursor B-cell ALL
Talha Badar, Hematologist/Oncologist at Mayo Clinic Comprehensive Cancer Center, posted on X/Twitter: "Upfront immunotherapy +/-…
Oct 15, 2023, 18:30 |
Blog
Suzanne Turner: Our very own SIOP 2023 Ambassador Venkatraman Radhakrishnan awarded the first Hans Peter Wagner prize for his impressive work.
Suzanne Turner, Professor of Childhood Cancer Biology at the University of Cambridge, posted on her…
Sep 26, 2023, 19:20 |
Insight
Venkatraman Radhakrishnan: Reduction in chemo dose intensity by 25% and adding Rituximab improves survival in pediatric high-grade B Non-Hodgkins Lymphoma in resource-limited settings.
Jul 28, 2023, 20:23 |
Drugs
What to do with Rituximab intolerant patients? - Timothy Voorhees
What to do with Rituximab intolerant patients? Don’t drop CD20 Ab therapy, switch to Obinutuzumab…
All:
5
Posts:
1 - 10
10 Most Promising Cancer Drugs Not Yet Approved: Solid Tumors - 2024 edition by OncoDaily
Elie G. Dib: Excited to share the results of the TAPUR study
OncoInfluencers: Dialogue with Fadlo R. Khuri, hosted by Gevorg Tamamyan
Cedars-Sinai is co-chairing a special AACR conference on transforming the field of Bladder Cancer on May 17-20
Barbara Jereczek-Fossa has been elected as the ESTRO President-elect!
Facebook
RSS Feed
Twitter
Linkedin
Youtube